Drive Therapeutics

Drive Therapeutics is developing targeted gene therapies to treat retinal diseases, focusing on restoring vision by addressing the underlying genetic causes. The company aims to improve patient outcomes by providing precise, long-lasting treatments that reduce the progression of vision loss.

Traction 4/10

Chapel Hill, United States · HQ

Founded 20193100+ followers

Biotechnology

Updated 23 months ago

Funding

Raised to date

$100KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Doug Gooding

Chief Executive Officer

Product

Features

Drive Therapeutics is developing targeted gene therapies to treat retinal diseases, focusing on restoring vision by addressing the underlying genetic causes. The company aims to improve patient outcomes by providing precise, long-lasting treatments that reduce the progression of vision loss.